NASDAQ Endocrinology Market News

Versartis Reports First Quarter 2016 Financial Results

MENLO PARK, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...

Aegerion Pharmaceuticals Observes World Lipodystrophy Day

CAMBRIDGE, MA, March 31, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical ...

Chiasma Announces Upcoming Events at ENDO 2016

WALTHAM, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical ...

DGAP-News: Aegerion Pharmaceuticals Observes World Lipodystrophy Day

DGAP-News: Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals Observes World Lipodystrophy Day 31.03.2016 / 08:59 The ...

Aegerion Pharmaceuticals Observes World Lipodystrophy Day

CAMBRIDGE, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical ...

DGAP-News: Aegerion Pharmaceuticals Observes World Lipodystrophy Day

DGAP-News: Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals Observes World Lipodystrophy Day 31.03.2016 / 08:59 The ...

Repros Announces Initiation of Formal Approval Process by the European Medicines Agency

THE WOODLANDS, Texas, March 15, 2016 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today ...